A large-scale coronavirus vaccine step-up campaign may not be necessary. This is one of the main figures in the development of vaccines. Oxford AstraZeneca Jabu said.
Professor Dame Sarah Gilbert said that for most people, immunity is “long-lasting” and suggested that additional doses should be used in countries with low vaccination rates.
Sanitation Committee Sajid Javid Zeng said that he expects to start a boosting program in late September, but he is still waiting for experts to advise on the scale of any activities to provide people with additional injections.
The U.S. Medicines and Healthcare Products Regulatory Agency (MHRA) stated that Pfizer AstraZeneca and AstraZeneca injections are safe to use as boosters, but the Joint Committee on Vaccination and Immunization (JCVI) has not yet provided advice to ministers.
Mrs. Sarah told the Daily Telegraph that the elderly and people with weakened immune systems should line up for the third injection, but “I don’t think we need to strengthen everyone.”
“As the virus spreads from person to person, it will mutate, adapt and evolve, just like the Delta variant,” she said.
“With these outbreaks, we hope to stop it as soon as possible.
“We will look at each situation; immunocompromised people and the elderly will receive boosters.
“But I don’t think we need to boost everyone. immunity Lasts well in most people. “
On Thursday, Mr. Javid said, “We are moving towards our booster program in England”, but he wanted “JCVI’s final opinion.”
“I believe our booster program will begin later this month, but I am still waiting for the final recommendation,” Mr. Javid said.
Mrs. Sarah has previously emphasized the huge differences in vaccination rates between different countries, suggesting that vaccines should be sent to areas with low availability, once for everyone, rather than three times for some people.
She told the Daily Telegraph: “We need to provide vaccines to countries where few people have been vaccinated so far.
“We must do better in this area. The first dose has the greatest impact.”
It is expected that JCVI will make recommendations on who should receive the booster injection within a few days.
It has already stated that a third dose should be given to people with severely weakened immune systems.
The expert team is reviewing the latest data from the Cov-Boost trial conducted by Southampton University Hospital.
The £19.3 million British clinical trial is testing Pfizer injections and injections from AstraZeneca, Moderna, Novavax, Johnson & Johnson, Valneva and CureVac’s Janssen.
The study is answering key questions, such as whether people who have taken two doses of AstraZeneca will get more benefits if they take a third dose of Pfizer.
The new MHRA guidelines say that anyone can take Pfizer booster, no matter what dose they have taken before.
However, AstraZeneca boosters will only be provided to those who have received AstraZeneca injections before.
According to the latest government data, as of September 8, the number of people receiving the first dose of vaccine was 48,344,566, an increase of 25,131 over the previous day, and the number of people receiving the vaccine at the same time was 43,708,906, an increase of 87,960.
The government said that as of Thursday, another 167 people had died within 28 days of testing positive for Covid-19, bringing the total in the UK to 133,841.
The government said that as of 9am on Thursday, there were 38,013 laboratory-confirmed Covid-19 cases in the UK.